Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Antibiotics often cause skin reactions, making them a major health concern.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Biologics for severe asthma have known side effects, but some new risks need more study.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Talquetamab may cause hair loss and skin issues.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

Voriconazole can cause serious side effects, especially in long-term use.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Histone modification is key in treating chronic inflammatory skin diseases.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.